$crvs
Corvus Pharmaceuticals' soquelitinib shows promising clinical data and novel ITK inhibition, but faces valuation concerns and scrutiny from short sellers.
About $crvs
Corvus Pharmaceuticals is a biotechnology company focused on developing novel therapeutics.
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Month: [---------] +250%
[--] Months: [---------] +118%
[--] Year: [---------] +57%
1-Year High: [-------] on 2026-01-20
1-Year Low: [-----] on 2025-03-16
Engagements by network (24h): Reddit: [--] YouTube: [--] X: [------]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
1-Year High: [---] on 2026-01-29
1-Year Low: [--] on 2025-03-16
Mentions by network (24h): Reddit: [--] YouTube: [--] X: [---]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $crvs in the last [--] hours which is down 25% from [---] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2026-01-21
1-Year Low: [--] on 2025-03-16
The most influential creators that mention $crvs in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @semodough | [--] | [------] | [--] | [------] |
| @financebully | [--] | [-----] | [--] | [-----] |
| @tradingsssss | [--] | [-----] | [--] | [-----] |
| @seedy19tron | [--] | [------] | [--] | [-----] |
| @HOThomasWPhelps | [--] | [-----] | [--] | [-----] |
| @A_May_MD | [--] | [------] | [--] | [-----] |
| @BiotechTV | [--] | [------] | [--] | [---] |
| @carinastankins | [--] | [---] | [--] | [---] |
| @realguenel | [--] | [--] | [--] | [---] |
| @Maximus_Holla | [--] | [------] | [--] | [---] |
Sentiment: 70%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 70%
Daily Average: 92%
[--] Month: 60% -22%
[--] Months: 60% -40%
[--] Year: 60% -32%
1-Year High: 100% on 2025-02-18
1-Year Low: 49% on 2025-10-26
Most Supportive Themes:
- Positive Clinical Data and Analyst Upgrades: (40%) Multiple posts highlight positive clinical trial data for soquelitinib, particularly in atopic dermatitis, and recent analyst upgrades, such as Mizuho raising the price target to $30.
- Novel Mechanism of Action (ITK Inhibition): (30%) There's significant discussion around Corvus's novel ITK inhibitor mechanism, which aims to reset the immune system by modulating T-cell phenotypes, differentiating it from existing therapies.
- Potential for Broader Applications and Long-Term Benefit: (20%) Posts suggest the ITK inhibition mechanism could have broader applications beyond atopic dermatitis and may lead to long-lasting immune memory or disease remission, potentially reducing the need for continuous treatment.
Most Critical Themes:
- Valuation Concerns and Short Seller Reports: (70%) Some posts raise concerns about the company's high valuation relative to its current stage (early Phase 2) and reference short seller reports questioning the data and commercial viability.
- Comparison to Competitors and Market Pricing: (30%) Discussions compare Corvus's drug to competitors like Dupilumab and JAK inhibitors, with some arguing that the market is pricing in certainty for a blockbuster drug that may not materialize.
Top $crvs Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$NKTR - Recent analyst price target $150+ 🌝. $abvx $crvs"
X Link @RiskHToIshqH 2026-02-16T21:04Z [----] followers, [----] engagements
"$CRVS #CEO $CRVS CEO Richard MILLER looks to have bought offering adding around 800k shares bringing his total to [----] million or 7.8% https://t.co/tbp8QwT2fy $CRVS CEO Richard MILLER looks to have bought offering adding around 800k shares bringing his total to [----] million or 7.8% https://t.co/tbp8QwT2fy"
X Link @AponiaAnalytics 2026-02-16T20:56Z [----] followers, [---] engagements
"$ALK $CRVS Here we go. https://discord.com/invite/9nbJyyfT7e https://discord.com/invite/9nbJyyfT7e"
X Link @Stella86245 2026-02-16T16:48Z [--] followers, [---] engagements
"$CRVS ⚠👀 Guys Don't miss the next move in a few hours. 💯🚀 https://discord.com/invite/jjbT64yGmJ https://discord.com/invite/jjbT64yGmJ"
X Link @Stock_Analysis3 2026-02-16T16:17Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing